Sahin, S. Et Al. 2012. The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung. EUROPEAN RESPIRATORY JOURNAL , vol.40 .

Sahin, S., Yilmaz, A., Demirag, F., Erdogan, Y., Yazici, U., & Karakaya, J., (2012). The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung. EUROPEAN RESPIRATORY JOURNAL , vol.40.

Sahin, Sezgi Et Al. "The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung," EUROPEAN RESPIRATORY JOURNAL , vol.40, 2012

Sahin, Sezgi Et Al. "The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung." EUROPEAN RESPIRATORY JOURNAL , vol.40, 2012

Sahin, S. Et Al. (2012) . "The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung." EUROPEAN RESPIRATORY JOURNAL , vol.40.

@article{article, author={Sezgi Sahin Et Al. }, title={The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung}, journal={EUROPEAN RESPIRATORY JOURNAL}, year=2012}